2011
DOI: 10.1016/j.ica.2011.01.048
|View full text |Cite
|
Sign up to set email alerts
|

The construction of a new POMs-based inorganic–organic hybrid framework involving in-situ ligand conversion from 1,3-bis(4-pyridyl)propane to isonicotinic acid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…POMs‐CPE was frequently used in applications to electrochemical tests due to its features, such as insoluble in water and common organic solvents, convenient and inexpensive fabrication, and stability , . Figure a and b show the electrochemical curves for 1 and 2 ‐CPE in 1 m H 2 SO 4 at different scan rates, which show three pairs of redox peaks from –550–1000 mV, their mean peak E 1/2 = ( E pa + E pc )/2 are 421 and 418 mV, 65 and 44 mV, –324 and –320 mV for 1 and 2 , respectively (scan rate: 20 mV · s –1 ).…”
Section: Resultsmentioning
confidence: 99%
“…POMs‐CPE was frequently used in applications to electrochemical tests due to its features, such as insoluble in water and common organic solvents, convenient and inexpensive fabrication, and stability , . Figure a and b show the electrochemical curves for 1 and 2 ‐CPE in 1 m H 2 SO 4 at different scan rates, which show three pairs of redox peaks from –550–1000 mV, their mean peak E 1/2 = ( E pa + E pc )/2 are 421 and 418 mV, 65 and 44 mV, –324 and –320 mV for 1 and 2 , respectively (scan rate: 20 mV · s –1 ).…”
Section: Resultsmentioning
confidence: 99%
“…The exibility can be adjusted by changing the space length of the -(CH 2 ) nlinkage, it and plays a signicant role in constructing fascinating POMCFs. To date, plenty of exible N-donor ligands have been designed and introduced into POMCFs (Scheme 2), including bis-pyridine, 29,[38][39][40][41][42][43][44][45][46] bis-imidazole, [47][48][49][50][51][52][53][54][55][56][57][58][59][60][61] bis-triazole, [62][63][64][65][66][67][68][69][70] bis-benzimidazole, 71 bis-tetrazole, 72,73 bis-pyridyl-bisamide, 16,74,75 bis[2-(4-pyridyl)benzimidazole] derivatives. 76 Moreover, to date, abundant POMCFs with diverse architectures modied by exible N-donor ligands have been isolated.…”
Section: Introductionmentioning
confidence: 99%